HEADER IMMUNE SYSTEM 03-JUN-15 5BUH TITLE INFLUENZA PB2 BOUND TO A HYDROXYMETHYL AZAINDOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYMERASE BASIC PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RNA-DIRECTED RNA POLYMERASE SUBUNIT P3; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: N-TERMINAL CLONING ARTIFACT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 383596; SOURCE 4 STRAIN: A/BEIJING/39/1975 H3N2; SOURCE 5 GENE: PB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B.1 KEYWDS SMALL MOLECULE INHIBITOR, POLYMERASE, INFLUENZA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.D.JACOBS REVDAT 4 06-MAR-24 5BUH 1 REMARK REVDAT 3 01-NOV-17 5BUH 1 REMARK REVDAT 2 01-MAR-17 5BUH 1 JRNL REVDAT 1 08-JUN-16 5BUH 0 JRNL AUTH U.K.BANDARAGE,M.P.CLARK,E.PEROLA,H.GAO,M.D.JACOBS,A.TSAI, JRNL AUTH 2 J.GILLESPIE,J.M.KENNEDY,F.MALTAIS,M.W.LEDEBOER,I.DAVIES, JRNL AUTH 3 W.GU,R.A.BYRN,K.NTI ADDAE,H.BENNETT,J.R.LEEMAN,S.M.JONES, JRNL AUTH 4 C.O'BRIEN,C.MEMMOTT,Y.BENNANI,P.S.CHARIFSON JRNL TITL NOVEL 2-SUBSTITUTED 7-AZAINDOLE AND 7-AZAINDAZOLE ANALOGUES JRNL TITL 2 AS POTENTIAL ANTIVIRAL AGENTS FOR THE TREATMENT OF JRNL TITL 3 INFLUENZA. JRNL REF ACS MED CHEM LETT V. 8 261 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28197323 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00487 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 6915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 339 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.68 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1934 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1970 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1836 REMARK 3 BIN R VALUE (WORKING SET) : 0.1907 REMARK 3 BIN FREE R VALUE : 0.3274 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.07 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1280 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.73850 REMARK 3 B22 (A**2) : 0.73850 REMARK 3 B33 (A**2) : -1.47690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.304 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.391 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.218 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.421 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.223 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1367 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1864 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 507 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 31 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 224 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1367 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 174 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1507 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.13 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.73 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|21 - A|183 } REMARK 3 ORIGIN FOR THE GROUP (A): -37.8885 -0.5611 2.8317 REMARK 3 T TENSOR REMARK 3 T11: 0.0054 T22: -0.2055 REMARK 3 T33: -0.2161 T12: 0.0585 REMARK 3 T13: 0.0517 T23: 0.0279 REMARK 3 L TENSOR REMARK 3 L11: 1.4676 L22: 9.2360 REMARK 3 L33: 3.8796 L12: -0.3177 REMARK 3 L13: 0.2095 L23: 3.9209 REMARK 3 S TENSOR REMARK 3 S11: -0.0833 S12: 0.1187 S13: -0.0245 REMARK 3 S21: -0.6418 S22: 0.1358 S23: -0.0245 REMARK 3 S31: -0.4500 S32: 0.1979 S33: -0.0524 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BUH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210554. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6918 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 26.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.38600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1 MICROL PROTEIN SOLUTION (2.8 MG/ML REMARK 280 PROTEIN, 50 MM TRIS BUFFER PH 8, 200 MM SODIUM CHLORIDE, 2 MM REMARK 280 DITHIOTHREITOL, 1 MM ANTHRAQUINONE-2,6-DISULFONIC ACID DISODIUM REMARK 280 SALT, 7.5 MM GTP) AND 0.4 ?L WELL SOLUTION (1.5 M SODIUM FORMATE, REMARK 280 100 MM SODIUM CITRATE BUFFER PH 4.7, 10 MM DITHIOTHREITOL) WAS REMARK 280 SUSPENDED OVER 1 ML OF WELL SOLUTION. THE CRYSTALS WERE REMARK 280 TRANSFERRED TO A SOAKING SOLUTION (3.25 M SODIUM FORMATE, 100 MM REMARK 280 SODIUM CITRATE BUFFER PH 4.7) CONTAINING 1 MM SMALL-MOLECULE REMARK 280 INHIBITOR. CRYSTALS WERE INCUBATED APPROXIMATELY 15 HOURS T ROOM REMARK 280 TEMPERATURE, AND THEN TRANSFERRED TO A CRYO-PRESERVATIVE REMARK 280 SOLUTION (SOAKING SOLUTION WITH 25 % V/V GLYCEROL) PRIOR TO REMARK 280 FREEZING IN LIQUID NITROGEN., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.06533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.53267 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.79900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 9.26633 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.33167 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER CONFIRMED BY SIZE EXCLUSION CHROMATOGRAPHY REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 15 REMARK 465 HIS A 16 REMARK 465 MET A 17 REMARK 465 ARG A 18 REMARK 465 ILE A 19 REMARK 465 SER A 20 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 41 CG CD OE1 OE2 REMARK 470 ARG A 136 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 118 -3.98 59.96 REMARK 500 ASN A 156 49.08 -97.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4V7 A 201 DBREF 5BUH A 18 183 UNP Q30NP1 PB2_I75A0 318 483 SEQADV 5BUH GLY A 15 UNP Q30NP1 CLONING ARTIFACT SEQADV 5BUH HIS A 16 UNP Q30NP1 CLONING ARTIFACT SEQADV 5BUH MET A 17 UNP Q30NP1 CLONING ARTIFACT SEQADV 5BUH LYS A 89 UNP Q30NP1 ARG 389 CONFLICT SEQRES 1 A 169 GLY HIS MET ARG ILE SER SER SER PHE SER PHE GLY GLY SEQRES 2 A 169 PHE THR PHE LYS ARG THR SER GLY SER SER ILE LYS ARG SEQRES 3 A 169 GLU GLU GLU VAL LEU THR GLY ASN LEU GLN THR LEU LYS SEQRES 4 A 169 ILE ARG VAL HIS GLU GLY TYR GLU GLU PHE THR MET VAL SEQRES 5 A 169 GLY LYS ARG ALA THR ALA ILE LEU ARG LYS ALA THR ARG SEQRES 6 A 169 ARG LEU VAL GLN LEU ILE VAL SER GLY LYS ASP GLU GLN SEQRES 7 A 169 SER ILE ALA GLU ALA ILE ILE VAL ALA MET VAL PHE SER SEQRES 8 A 169 GLN GLU ASP CYS MET ILE LYS ALA VAL ARG GLY ASP LEU SEQRES 9 A 169 ASN PHE VAL ASN ARG ALA ASN GLN ARG LEU ASN PRO MET SEQRES 10 A 169 HIS GLN LEU LEU ARG HIS PHE GLN LYS ASP ALA LYS VAL SEQRES 11 A 169 LEU PHE GLN ASN TRP GLY ILE GLU HIS ILE ASP ASN VAL SEQRES 12 A 169 MET GLY MET VAL GLY VAL LEU PRO ASP MET THR PRO SER SEQRES 13 A 169 THR GLU MET SER MET ARG GLY ILE ARG VAL SER LYS MET HET 4V7 A 201 61 HETNAM 4V7 N-[(1R,3S)-3-({5-FLUORO-2-[5-FLUORO-2-(HYDROXYMETHYL)- HETNAM 2 4V7 1H-PYRROLO[2,3-B]PYRIDIN-3-YL]PYRIMIDIN-4-YL}AMINO) HETNAM 3 4V7 CYCLOHEXYL]PYRROLIDINE-1-CARBOXAMIDE FORMUL 2 4V7 C23 H27 F2 N7 O2 FORMUL 3 HOH *27(H2 O) HELIX 1 AA1 ASP A 90 SER A 105 1 16 HELIX 2 AA2 GLU A 107 ALA A 113 1 7 HELIX 3 AA3 ASN A 129 ASP A 141 1 13 HELIX 4 AA4 ALA A 142 TRP A 149 1 8 SHEET 1 AA1 8 SER A 22 PHE A 25 0 SHEET 2 AA1 8 PHE A 28 GLY A 35 -1 O PHE A 30 N PHE A 23 SHEET 3 AA1 8 GLU A 61 VAL A 66 -1 O VAL A 66 N THR A 29 SHEET 4 AA1 8 ALA A 70 ALA A 77 -1 O LYS A 76 N GLU A 61 SHEET 5 AA1 8 ARG A 80 GLY A 88 -1 O ARG A 80 N ALA A 77 SHEET 6 AA1 8 ILE A 178 SER A 181 1 O SER A 181 N VAL A 86 SHEET 7 AA1 8 MET A 160 VAL A 163 -1 N VAL A 161 O VAL A 180 SHEET 8 AA1 8 PRO A 169 SER A 170 -1 O SER A 170 N GLY A 162 SHEET 1 AA2 2 ILE A 38 LEU A 45 0 SHEET 2 AA2 2 THR A 51 GLU A 58 -1 O ILE A 54 N GLU A 42 SHEET 1 AA3 2 ILE A 151 HIS A 153 0 SHEET 2 AA3 2 MET A 173 MET A 175 -1 O SER A 174 N GLU A 152 SITE 1 AC1 11 PHE A 23 PHE A 25 ARG A 32 HIS A 57 SITE 2 AC1 11 GLU A 61 PHE A 63 LYS A 76 PHE A 104 SITE 3 AC1 11 GLN A 106 ASN A 129 MET A 131 CRYST1 81.801 81.801 55.598 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012225 0.007058 0.000000 0.00000 SCALE2 0.000000 0.014116 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017986 0.00000